Annika Hanberg Wiklund

Title: Annika Hanberg Wiklund: Innovator in Cancer Research

Introduction

Annika Hanberg Wiklund is a prominent inventor based in Stocksund, Sweden. She has made significant contributions to the field of cancer research through her innovative work. Her research focuses on developing tools that enhance the understanding of cancer mechanisms and potential treatments.

Latest Patents

Annika holds a patent for a "Transgenic mouse expressing constitutively active hydrocarbon receptor." This invention provides powerful tools for studying cancer, particularly through a novel expression construct for a constitutively active hydrocarbon receptor, CA-AhR. The patent includes transgenic non-human animals, preferably mammals, that express CA-AhR in various tissues. This animal model serves as a foundation for novel methods in cancer research, including the screening of drug candidates and the investigation of molecular mechanisms related to stomach cancer and highly differentiated adenocarcinoma.

Career Highlights

Annika is associated with Index Pharmaceuticals AB, where she continues to advance her research in cancer biology. Her work has the potential to lead to significant breakthroughs in understanding and treating cancer.

Collaborations

Annika collaborates with notable colleagues, including Lorenz Poellinger and Jaqueline McGuire, who contribute to her research endeavors.

Conclusion

Annika Hanberg Wiklund's innovative work in cancer research exemplifies the impact of transgenic models in understanding complex diseases. Her contributions are paving the way for future advancements in cancer treatment and research methodologies.